Learned by Reading
In the ICWSM 2009 Weblog Corpus:
The authors review the current treatment of chronic hepatitis B, with a focus on diagnosis and management of resistance and active management of suboptimal responses.
(Parse)
(S1 (S (NP (DT The) (NNS authors))
(VP (VBP review)
(NP (NP (DT the) (JJ current) (NN treatment))
(PP (IN of)
(NP (JJ chronic) (NN hepatitis) (NN B))))
(, ,)
(PP (IN with)
(NP (NP (DT a) (NN focus))
(PP (IN on)
(NP (NP (NP (NN diagnosis) (CC and) (NN management))
(PP (IN of)
(NP (NN resistance))))
(CC and)
(NP (NP (JJ active) (NN management))
(PP (IN of)
(NP (JJ suboptimal) (NNS responses)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Lamivudine for patients with chronic hepatitis B and advanced liver disease.
(Parse)
(S1 (FRAG (RB Lamivudine)
(PP (IN for)
(NP (NP (NNS patients))
(PP (IN with)
(NP (NP (JJ chronic) (NN hepatitis) (NN B)) (CC and)
(NP (JJ advanced) (NN liver) (NN disease)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Chronic Hepatitis B can develop into potentially fatal conditions such as liver cancer and cirrhosis.
(Parse)
(S1 (S (NP (JJ Chronic) (NN Hepatitis) (NN B))
(VP (MD can)
(VP (VB develop)
(PP (IN into)
(NP (NP (ADJP (RB potentially) (JJ fatal)) (NNS conditions))
(PP (JJ such) (IN as)
(NP (NP (NN liver) (NN cancer)) (CC and)
(NP (NNS cirrhosis)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
In the United States, chronic hepatitis B is the underlying cause of an estimated 2,000? 4,000 deaths each year from cirrhosis and liver cancer.
(Parse)
(S1 (S (PP (IN In)
(NP (DT the) (NNP United) (NNPS States)))
(, ,)
(NP (JJ chronic) (NN hepatitis) (NN B))
(VP (AUX is)
(NP (NP (DT the) (JJ underlying) (NN cause))
(PP (IN of)
(NP (NP (NP (DT an) (VBN estimated) (CD 2,000) (. ?)) (CD 4,000) (NNS deaths))
(NP (DT each) (NN year))
(PP (IN from)
(NP (NN cirrhosis) (CC and) (NN liver) (NN cancer))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Interestingly, sirolimus may promote lymphocele formation in renal transplant recipients, including those presenting with chronic hepatitis B or C. Herein, we report a case of late spontaneous decapsulation with subcapsular hematoma formation developing 12 years after receipt of a cadaveric allograft.
(Parse)
(S1 (S (S (ADVP (RB Interestingly)) (, ,)
(NP (NNS sirolimus))
(VP (MD may)
(VP (VB promote)
(NP (NN lymphocele) (NN formation))
(PP (IN in)
(NP (NP (JJ renal) (NN transplant) (NNS recipients)) (, ,)
(PP (VBG including)
(NP (NP (DT those))
(VP (VBG presenting)
(PP (IN with)
(NP (JJ chronic) (NN hepatitis) (NN B) (CC or) (NN C)))))
(. .) (ADVP (RB Herein)) (, ,)
(NP (PRP we))
(VP (VBP report)
(NP (NP (DT a) (NN case))
(PP (IN of)
(NP (JJ late) (JJ spontaneous) (NN decapsulation))))
(PP (IN with)
(NP (JJ subcapsular) (NN hematoma) (NN formation)))
(S (VP (VBG developing)
(NP (CD 12) (NNS years))
(PP (IN after)
(NP (NP (NN receipt))
(PP (IN of)
(NP (DT a) (JJ cadaveric) (NN allograft)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Only 5–10 percent of adults infected with HBV go on to develop chronic infection and are termed chronic carriers – two – thirds of whom do not themselves become sick or die of the virus; but they can transmit it to other people; one third develop chronic hepatitis B, a disease of the liver that can be very serious.
(Parse)
(S1 (FRAG (NP (QP (RB Only) (CD 5)))
(: -)
(S (S (NP (NP (CD 10) (NN percent))
(PP (IN of)
(NP (NP (NNS adults))
(VP (VBN infected)
(PP (IN with)
(NP (NNP HBV))))
(VP (VBP go) (PRT (RP on))
(S (VP (TO to)
(VP (VP (VB develop)
(NP (JJ chronic) (NN infection)))
(CC and)
(VP (AUX are)
(VP (VBN termed)
(NP (NP (NN chronic) (NNS carriers)) (: -)
(NP (CD two)) (: -)
(NP (NP (NNS thirds))
(PP (IN of)
(SBAR (WHNP (WP whom))
(S (VP (AUX do) (RB not)
(S (NP (PRP themselves))
(VP (VP (VB become)
(ADJP (JJ sick)))
(CC or)
(VP (VB die)
(PP (IN of)
(NP (DT the) (NN virus))))
(: ;) (CC but)
(S (NP (PRP they))
(VP (MD can)
(VP (VB transmit)
(NP (PRP it))
(PP (TO to)
(NP (JJ other) (NNS people)))
(: ;)
(S (NP (CD one) (NN third))
(VP (VB develop)
(NP (NP (JJ chronic) (NN hepatitis) (NN B)) (, ,)
(NP (NP (DT a) (NN disease))
(PP (IN of)
(NP (DT the) (NN liver)))
(SBAR (WHNP (WDT that))
(S (VP (MD can)
(VP (AUX be)
(ADJP (RB very) (JJ serious)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
New Guidance Also Issued on Patient Management for Those Infected The U.S. Centers for Disease Control and Prevention (CDC) today published new recommendations for health care providers that are designed to increase routine testing in the United States for chronic hepatitis B, a major cause of li
(Parse)
(S1 (S (NP (NP (JJ New) (NN Guidance))
(VP (ADVP (RB Also)) (VBN Issued)
(PP (IN on)
(NP (JJ Patient) (NN Management)))
(PP (IN for)
(NP (NP (DT Those) (JJ Infected) (NNP The) (NNP U.S.) (NNPS Centers))
(PP (IN for)
(NP (NP (NNP Disease) (NNP Control)) (CC and)
(NP (NP (NNP Prevention)) (PRN (-LRB- -LRB-)
(NP (NNP CDC)) (-RRB- -RRB-)))
(NP (NN today))
(VP (VBN published)
(NP (NP (JJ new) (NNS recommendations))
(PP (IN for)
(NP (NN health) (NN care) (NNS providers)))
(SBAR (WHNP (WDT that))
(S (VP (AUX are)
(VP (VBN designed)
(S (VP (TO to)
(VP (VB increase)
(NP (JJ routine) (NN testing))
(PP (IN in)
(NP (DT the) (NNP United) (NNPS States)))
(PP (IN for)
(NP (NP (JJ chronic) (NN hepatitis) (NN B)) (, ,)
(NP (NP (DT a) (JJ major) (NN cause))
(PP (IN of)
(NP (NNP li)))))))))))))))))
In the ICWSM 2009 Weblog Corpus:
FDA Approves VireadR For Chronic Hepatitis B In Adults.
(Parse)
(S1 (S (NP (NNP FDA))
(VP (VBZ Approves)
(NP (NNP VireadR))
(PP (IN For)
(NP (JJ Chronic) (NN Hepatitis) (NN B)))
(PP (IN In)
(NP (NNS Adults))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Chronic hepatitis B infects 400 million people worldwide, many of them children.
(Parse)
(S1 (S (NP (JJ Chronic) (NN hepatitis) (NN B))
(VP (VBZ infects)
(NP (NP (QP (CD 400) (CD million)) (NNS people))
(ADJP (NNP worldwide) (, ,) (JJ many)
(PP (IN of)
(NP (DT them) (NNS children)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
NICE (National Institute for Health and Clinical Excellence) has published guidance that recommends Baraclude (R) (entecavir) as an option for treatment of eligible patients with chronic hepatitis B (CHB).
(Parse)
(S1 (S (NP (NP (JJ NICE)) (PRN (-LRB- -LRB-)
(NP (NP (NNP National) (NNP Institute))
(PP (IN for)
(NP (NNP Health) (CC and) (JJ Clinical) (NNP Excellence))))
(-RRB- -RRB-)))
(VP (AUX has)
(VP (VBN published)
(NP (NP (NN guidance))
(SBAR (WHNP (WDT that))
(S (VP (VBZ recommends)
(NP (NP (NNP Baraclude)) (PRN (-LRB- -LRB-) (NN R) (-RRB- -RRB-)))
(PRN (-LRB- -LRB-) (JJ entecavir) (-RRB- -RRB-))
(PP (IN as)
(NP (NP (DT an) (NN option))
(PP (IN for)
(NP (NP (NN treatment))
(PP (IN of)
(NP (NP (JJ eligible) (NNS patients))
(PP (IN with)
(NP (JJ chronic) (NN hepatitis) (NN B)))
(PRN (-LRB- -LRB-) (NN CHB) (-RRB- -RRB-)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Chronic hepatitis B disproportionately affects Asian Americans, who represent nearly half of all cases and are one of the fastest – growing population groups in the country.
(Parse)
(S1 (S (NP (JJ Chronic) (NN hepatitis) (NN B))
(VP (ADVP (RB disproportionately)) (VBZ affects)
(NP (NP (NNP Asian) (NNPS Americans)) (, ,)
(SBAR (WHNP (WP who))
(S (VP (VP (VBP represent)
(NP (NP (QP (RB nearly) (NN half)))
(PP (IN of)
(NP (DT all) (NNS cases)))))
(CC and)
(VP (AUX are)
(NP (NP (NP (CD one))
(PP (IN of)
(NP (DT the) (JJS fastest))))
(: -)
(NP (NP (VBG growing) (NN population) (NNS groups))
(PP (IN in)
(NP (DT the) (NN country)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Chronic hepatitis B infects 400 million people worldwide, many of them children.
(Parse)
(S1 (S (NP (JJ Chronic) (NN hepatitis) (NN B))
(VP (VBZ infects)
(NP (NP (QP (CD 400) (CD million)) (NNS people))
(ADJP (NNP worldwide) (, ,) (JJ many)
(PP (IN of)
(NP (DT them) (NNS children)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Patients should tell their doctor if they have had liver disease such as chronic hepatitis B or C as they are at increased risk for severe and potentially fatal liver adverse events.
(Parse)
(S1 (S (NP (NNS Patients))
(VP (MD should)
(VP (VB tell)
(NP (PRP$ their) (NN doctor))
(SBAR (IN if)
(S (NP (PRP they))
(VP (AUX have)
(VP (AUX had)
(NP (NN liver) (NN disease))
(PP (JJ such) (IN as)
(NP (JJ chronic) (NN hepatitis) (NN B) (CC or) (NN C)))
(SBAR (IN as)
(S (NP (PRP they))
(VP (AUX are)
(PP (IN at)
(NP (NP (VBN increased) (NN risk))
(PP (IN for)
(NP (ADJP (ADJP (JJ severe)) (CC and)
(ADJP (RB potentially) (JJ fatal)))
(NN liver) (JJ adverse) (NNS events)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
S Viread for chronic hepatitis B treatment in.
(Parse)
(S1 (FRAG (NP (NP (NNP S) (NNP Viread))
(PP (IN for)
(NP (JJ chronic) (NN hepatitis) (NN B))))
(ADVP (NN treatment) (IN in)) (. .)))
In the ICWSM 2009 Weblog Corpus:
Food and Drug Administration Approves VireadR for Chronic Hepatitis B. Tropical Storm Fay now a tropical depression.
(Parse)
(S1 (S (NP (NNP Food) (CC and) (NNP Drug) (NNP Administration))
(VP (VBZ Approves)
(NP (NNP VireadR))
(PP (IN for)
(NP (JJ Chronic) (NN Hepatitis) (NN B)))
(. .)
(NP (JJ Tropical) (NN Storm) (NNP Fay)) (ADVP (RB now))
(NP (DT a) (JJ tropical) (NN depression)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Results from both studies show that a significantly greater Trazodone withdrawal symptoms of patients with chronic hepatitis B who received Viread achieved a complete response to treatment compared to those who received Hepsera.
(Parse)
(S1 (S (NP (NP (NNS Results))
(PP (IN from)
(NP (DT both) (NNS studies))))
(VP (VBP show)
(SBAR (IN that)
(S (NP (NP (DT a)
(ADJP (RB significantly) (JJR greater)) (NNP Trazodone) (NN withdrawal) (NNS symptoms))
(PP (IN of)
(NP (NP (NNS patients))
(PP (IN with)
(NP (JJ chronic) (NN hepatitis) (NN B)))
(SBAR (WHNP (WP who))
(S (VP (VBD received)
(NP (NNP Viread)))))
(VP (VBD achieved)
(NP (NP (DT a) (JJ complete) (NN response))
(PP (TO to)
(NP (NN treatment)))
(PP (VBN compared)
(PP (TO to)
(NP (NP (DT those))
(SBAR (WHNP (WP who))
(S (VP (VBD received)
(NP (NNP Hepsera))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Viread is now also indicated for the treatment of chronic hepatitis B in adults.
(Parse)
(S1 (S (NP (NNP Viread))
(VP (AUX is) (ADVP (RB now)) (ADVP (RB also))
(VP (VBN indicated)
(PP (IN for)
(NP (NP (DT the) (NN treatment))
(PP (IN of)
(NP (JJ chronic) (NN hepatitis) (NN B)))))
(PP (IN in)
(NP (NNS adults)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Chronic hepatitis B infects 400 million people worldwide, many of them children.
(Parse)
(S1 (S (NP (JJ Chronic) (NN hepatitis) (NN B))
(VP (VBZ infects)
(NP (NP (QP (CD 400) (CD million)) (NNS people))
(ADJP (NNP worldwide) (, ,) (JJ many)
(PP (IN of)
(NP (DT them) (NNS children)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Chronic hepatitis B is a common and potentially fatal liver disease caused by the hepatitis B virus, which is up to 100 times more easily transmitted than HIV.
(Parse)
(S1 (S (NP (JJ Chronic) (NN hepatitis) (NN B))
(VP (AUX is)
(NP (NP (DT a)
(ADJP (ADJP (JJ common)) (CC and)
(ADJP (RB potentially) (JJ fatal)))
(NN liver) (NN disease))
(VP (VBN caused)
(PP (IN by)
(NP (NP (DT the) (NN hepatitis) (NN B) (NN virus)) (, ,)
(SBAR (WHNP (WDT which))
(S (VP (AUX is)
(ADJP (ADVP (QP (IN up) (TO to) (CD 100) (NNS times)) (RBR more) (RB easily)) (VBN transmitted)
(PP (IN than)
(NP (NNP HIV)))
(. .)))
And 230 more sentences.